Editorial of Special Column on A New Era of Nanobiomaterial-based Drug Delivery

[1]  Jun Wang,et al.  Mucosal vaccine delivery: A focus on the breakthrough of specific barriers , 2022, Acta Pharmaceutica Sinica B.

[2]  Zhiai Xu,et al.  Dual-targeting prodrug nanotheranostics for NIR-Ⅱ fluorescence imaging-guided photo-immunotherapy of glioblastoma , 2022, Acta pharmaceutica Sinica. B.

[3]  Pengyu Li,et al.  Multi-functional vesicles improve Helicobacter pylori eradication by a comprehensive strategy based on complex pathological microenvironment , 2022, Acta pharmaceutica Sinica. B.

[4]  P. Liang,et al.  Combination therapy using microwave ablation and d-mannose-chelated iron oxide nanoparticles inhibits hepatocellular carcinoma progression , 2022, Acta pharmaceutica Sinica. B.

[5]  Yanli Zhao,et al.  Critical involvement of lysyl oxidase in seizure-induced neuronal damage through ERK-Alox5-dependent ferroptosis and its therapeutic implications , 2022, Acta pharmaceutica Sinica. B.

[6]  Qiaobing Xu,et al.  Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs , 2022, Acta pharmaceutica Sinica. B.

[7]  Huzhi Zheng,et al.  A mitochondria-targeting lipid–small molecule hybrid nanoparticle for imaging and therapy in an orthotopic glioma model , 2022, Acta pharmaceutica Sinica. B.

[8]  Yuzhu Hu,et al.  A BRD4 PROTAC nanodrug for glioma therapy via the intervention of tumor cells proliferation, apoptosis and M2 macrophages polarization , 2022, Acta pharmaceutica Sinica. B.

[9]  A. Wu,et al.  Chemotherapeutic nanomaterials in tumor boundary delineation: Prospects for effective tumor treatment , 2022, Acta pharmaceutica Sinica. B.

[10]  Shaobing Zhou,et al.  A hybrid bacterium with tumor-associated macrophage polarization for enhanced photothermal-immunotherapy , 2021, Acta pharmaceutica Sinica. B.

[11]  Y. Liu,et al.  Liposome-based multifunctional nanoplatform as effective therapeutics for the treatment of retinoblastoma , 2021, Acta pharmaceutica Sinica. B.

[12]  Jing-yu Fan,et al.  Traditional herbal medicine and nanomedicine: Converging disciplines to improve therapeutic efficacy and human health. , 2021, Advanced drug delivery reviews.

[13]  Z. Qian,et al.  Tumor-targeted/reduction-triggered composite multifunctional nanoparticles for breast cancer chemo-photothermal combinational therapy , 2021, Acta pharmaceutica Sinica. B.

[14]  Tianliang Li,et al.  Bispecific prodrug nanoparticles circumventing multiple immune resistance mechanisms for promoting cancer immunotherapy , 2021, Acta pharmaceutica Sinica. B.

[15]  Ling Wang,et al.  Enzyme-instructed and mitochondria-targeting peptide self-assembly to efficiently induce immunogenic cell death , 2021, Acta pharmaceutica Sinica. B.

[16]  Haijun Yu,et al.  From Design to Clinic: Engineered Nanobiomaterials for Immune Normalization Therapy of Cancer , 2021, Advanced materials.

[17]  G. Terstappen,et al.  Strategies for delivering therapeutics across the blood–brain barrier , 2021, Nature Reviews Drug Discovery.

[18]  Nicholas A. Peppas,et al.  Engineering precision nanoparticles for drug delivery , 2020, Nature reviews. Drug discovery.

[19]  Xiaoyuan Chen,et al.  Rethinking cancer nanotheranostics. , 2017, Nature reviews. Materials.